Clinical evidence

Comparative study – in vitro

A comparative study performed by RISE (Research Institutes of Sweden) to be published soon confirms the benefits of using LuerJack. When comparing a conventional syringe with a safety needle vs. LuerJack with a conventional needle, LuerJack reduces the risk of cross-contamination by 46% and the risk of a needlestick injury by 50%.

 

MaM-20170517-3 Clinical Evidence summary